[HTML][HTML] What can National TB Control Programmes in low-and middle-income countries do to end tuberculosis by 2030?

AD Harries, Y Lin, AMV Kumar, S Satyanarayana… - …, 2018 - ncbi.nlm.nih.gov
The international community has committed to ending the tuberculosis (TB) epidemic by
2030. This will require multi-sectoral action with a focus on accelerating socio-economic …

Implementation of Xpert MTB/RIF in 22 high tuberculosis burden countries: are we making progress?

D Cazabon, A Suresh, C Oghor, ZZ Qin… - European …, 2017 - Eur Respiratory Soc
Implementation of Xpert MTB/RIF in 22 high tuberculosis burden countries: are we making
progress? | European Respiratory Society Skip to main content Main menu Home Current issue …

Management of rifampicin‐resistant TB: programme indicators and care cascade analysis in South Africa

E De Vos, L Scott, Y Voss De Lima… - … of Tuberculosis and …, 2021 - ingentaconnect.com
BACKGROUND: Xpert® MTB/RIF was expected to revolutionise the management of
rifampicin‐resistant TB (RR‐TB) by enabling rapid and decentralised diagnosis of rifampicin …

Magnitude of Mycobacterium tuberculosis Infection and Its Resistance to Rifampicin Using Xpert-MTB/RIF Assay Among Presumptive Tuberculosis Patients at Motta …

TA Demissie, D Belayneh - Infection and Drug Resistance, 2021 - Taylor & Francis
Background Mycobacterium Tuberculosis (MTB) and its drug resistance form are the
devastating infectious diseases in the world. It is the major cause of morbidity and mortality …

Estimating the effect of a rifampicin resistant tuberculosis diagnosis by the Xpert MTB/RIF assay on two-year mortality

E De Vos, D Westreich, L Scott… - PLOS Global Public …, 2023 - journals.plos.org
Studies assessing patient-centred outcomes of novel rifampicin resistant tuberculosis (RR-
TB) diagnostics are rare and mostly apply conventional methods which may not adequately …

Effect of reliance on Xpert MTB/RIF on time to treatment and multidrug-resistant tuberculosis treatment outcomes in Tanzania: a retrospective cohort study

E Mollel, I Lekule, L Lynen, T Decroo - International Health, 2019 - academic.oup.com
Abstract Background During 2009–2013, Xpert MTB/RIF testing was decentralized in
Tanzania. Standardized treatment of multidrug-resistant/rifampicin-resistant tuberculosis …

[HTML][HTML] Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain® Line Probe Assay …

C Timire, C Sandy, AMV Kumar, M Ngwenya… - International Journal of …, 2019 - Elsevier
Objectives To determine the proportion of rifampicin-resistant tuberculosis (RR-TB) patients
who accessed second-line drug susceptibility testing (SL-DST) results following introduction …

Impact of scaling up Xpert® MTB/RIF testing for the detection of rifampicin-resistant TB cases in Karachi, Pakistan

WM Awan, SMA Zaidi, SS Habib… - … of tuberculosis and …, 2018 - ingentaconnect.com
SETTING: Pakistan ranks fourth among the countries with a high burden of multidrug-
resistant tuberculosis (MDR-TB), with only 19.2% of the 15 000 estimated incident cases …

How well does the process of screening and diagnosis work for HIV-infected persons identified with presumptive tuberculosis who are attending HIV care and …

KC Takarinda, R Choto, C Sandy… - Transactions of The …, 2018 - academic.oup.com
Background Intensified TB case finding is recommended for all HIV-infected persons
regularly attending HIV care and treatment clinics. The authors aimed to determine how well …

应用GeneXpert MTB/RIF 对肺外结核的快速检测及评估

赵金云, 陈雪芳, 许文芳, 金法祥 - 中国微生态学杂志, 2021 - cjm.dmu.edu.cn
目的评估GeneXpert MTB/RIF 检测肺外结核分枝杆菌的准确性, 并与传统方法进行比较.
方法选取2016 年6 月至2017 年6 月在本院就诊的144 例疑似肺外结核病患者 …